Citations

Citations to this article as recorded by  

• Sesquiterpene Lactones as Promising Phytochemicals to Cease Metastatic Propagation of Cancer
  Fatemeh Mehdikhani, Homa Hajimehdipoor, Mojgan Tansaz, Marc Maresca, Sadegh Rajabi
  Biomolecules.2025; 15(2): 268.     CrossRef
• Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived Dimethylaminomicheliolide and Micheliolide
  Jian Li, Xin Li, Hongwei Liu
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Cyanidin-3-O-glucoside inhibits the malignant progression of colorectal cancer by regulating Kruppel-like factor 4-mediated ERK/p38 signaling pathway
  Jian Chang, Geqiong Xiao
  Toxicology and Applied Pharmacology.2025; 497: 117268.     CrossRef
• Novel formulation of parthenolide-loaded liposome coated with chitosan and evaluation of its potential anticancer effects in vitro
  Parisa Karimian Ensaf, Mohammad Taghi Goodarzi, Masoud Homayouni Tabrizi, Ali Neamati, Samira Sadat Hosseinyzadeh
  Molecular Biology Reports.2024;[Epub]     CrossRef
• Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis
  Chou-Yi Hsu, Sadegh Rajabi, Maryam Hamzeloo-Moghadam, Abhinav Kumar, Marc Maresca, Pallavi Ghildiyal
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Exploring the Phytochemistry, Signaling Pathways, and Mechanisms of Action of Tanacetum parthenium (L.) Sch.Bip.: A Comprehensive Literature Review
  Ali Kashkooe, Atefeh Jalali, Mohammad M. Zarshenas, Azadeh Hamedi
  Biomedicines.2024; 12(10): 2297.     CrossRef
• Bitter taste signaling in cancer
  Ana R. Costa, Ana C. Duarte, Ana R. Costa-Brito, Isabel Gonçalves, Cecília R.A. Santos
  Life Sciences.2023; 315: 121363.     CrossRef
• Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells
  Adriana S. Gehren, Waldemir F. de Souza, Annie C. M. Sousa‐Squiavinato, Diego A. A. Ramos, Bruno R. B. Pires, Eliana S. F. W. Abdelhay, Jose A. Morgado‐Diaz
  Cell Biology International.2023; 47(9): 1638.     CrossRef
• Novel shikonin derivative suppresses tumor growth and metastasis intervention of Wnt/β-catenin pathway
  Hongwei Han, Zhongling Wen, Xiaohui Lai, Minkai Yang, Jiangyan Fu, Liangjie Yang, Qingqing Chen, Yudi Ma, Wencai Jie, Changyi Wang, Tongming Yin, Guihua Lu, Xiaoming Wang, Shucun Sun, Quan Zhao, Jinliang Qi, Hongyan Lin, Yonghua Yang
  Process Biochemistry.2023; 132: 297.     CrossRef
• Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition
  Soad L. Kabil, Hayam E. Rashed, Noura Mostafa Mohamed, Nisreen E. Elwany
  Life Sciences.2023; 331: 122037.     CrossRef
• TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer
  Sumeet Singh, Vinita Gouri, Mukesh Samant
  Medical Oncology.2023;[Epub]     CrossRef
• Decoding Systems Biology of Inflammation Signatures in Cancer Pathogenesis: Pan-Cancer Insights from 12 Common Cancers
  Beste Turanli
  OMICS: A Journal of Integrative Biology.2023; 27(10): 483.     CrossRef
• Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
  Daniela Carlisi, Marianna Lauricella, Antonella D’Anneo, Anna De Blasio, Adriana Celesia, Giovanni Pratelli, Antonietta Notaro, Giuseppe Calvaruso, Michela Giuliano, Sonia Emanuele
  Biomedicines.2022; 10(2): 514.     CrossRef
• Parthenolide reverses the epithelial to mesenchymal transition process in breast cancer by targeting TGFbeta1: In vitro and in silico studies
  Hazera Binte Sufian, Julianna Maria Santos, Zeina S. Khan, Sobia Ahsan Halim, Ajmal Khan, Maliha Tabassum Munir, MD Khurshidul Zahid, Ahmed Al-Harrasi, Lauren S. Gollahon, Fazle Hussain, Shaikh Mizanoor Rahman
  Life Sciences.2022; 301: 120610.     CrossRef
• Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide
  Yubo Dong, Xuanjin Qian, Jian Li, Ahmed Faeq Hussein
  Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
• Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents
  Xingchen LIU, Xiaobing WANG
  Chinese Journal of Natural Medicines.2022; 20(11): 814.     CrossRef
• Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
  Chin King Looi, Ling-Wei Hii, Felicia Fei-Lei Chung, Chun-Wai Mai, Wei-Meng Lim, Chee-Onn Leong
  Cancers.2021; 13(8): 1786.     CrossRef
• Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
  Magdalena Rausch, Adriano Rutz, Pierre-Marie Allard, Céline Delucinge-Vivier, Mylène Docquier, Olivier Dormond, Paul J. Dyson, Jean-Luc Wolfender, Patrycja Nowak-Sliwinska
  Cancers.2021; 13(16): 3978.     CrossRef
• 6 α-Hydroxy-4[14], 10[15]-guainadien-8β, 12-olide induced cell cycle arrest via modulation of EMT and Wnt/β-catenin pathway in HER-2 positive breast cancer cells
  Gitanjali Javir, Kalpana Joshi, Vijay Khedkar, Supada Rojatkar
  The Journal of Steroid Biochemistry and Molecular Biology.2020; 197: 105514.     CrossRef
• Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth
  Xue Li, Lingmei Kong, Qihong Yang, Aizhu Duan, Xiaoman Ju, Bicheng Cai, Lin Chen, Tao An, Yan Li
  Journal of Biological Chemistry.2020; 295(11): 3576.     CrossRef
• Metabonomic study of the intervention effects of Parthenolide on anti-thyroid cancer activity
  Lili Yuan, Zhe Wang, Dongyang Zhang, Jiahe Wang
  Journal of Chromatography B.2020; 1150: 122179.     CrossRef
• ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF‐κB activation
  Xiao‐Han Jin, Yong‐Sheng Jia, Ye‐Hui Shi, Qiu‐Ying Li, Shi‐Qi Bao, Wen‐Ping Lu, Zhong‐Sheng Tong
  Journal of Cellular Biochemistry.2019; 120(2): 1386.     CrossRef
• Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
  Mona Dawood, Edna Ooko, Thomas Efferth
  Frontiers in Pharmacology.2019;[Epub]     CrossRef
• Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells
  Shi Mao Zhu, Yong Ran Park, Seung Yong Seo, In Hee Kim, Soo Teik Lee, Sang Wook Kim
  Intestinal Research.2019; 17(4): 527.     CrossRef
• Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer
  Luksana Chaiswing, William H. St. Clair, Daret K. St. Clair
  Antioxidants & Redox Signaling.2018; 29(13): 1237.     CrossRef
• Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression
  Wamidh H. Talib, Lina T. Al Kury
  Biomedicine & Pharmacotherapy.2018; 107: 1488.     CrossRef
• Synergistic effects and mechanisms of impressic acid or acankoreanogein in combination with docetaxel on prostate cancer
  Sen Jiang, Kun Zhang, Yan He, Xuetao Xu, Dongli Li, Shupeng Cheng, Xi Zheng
  RSC Advances.2018; 8(5): 2768.     CrossRef
• The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis
  Xin Jin, Jianping Zhou, Zhenhai Zhang, Huixia Lv
  Artificial Cells, Nanomedicine, and Biotechnology.2018; 46(sup3): 931.     CrossRef